Taysha
deep pipeline of gene therapies targeting disorders | Taysha
Company
Deck Type
IPO
Sector
Industry
Deck date
September 2020
Slide
38 of 66
Related slides by other companies
argenx SE
Results
July 2021
deep antibody pipeline of differentiated candidates | argenx SE
GreenLight
SPAC
August 2021
human health pipeline focused on large and significant markets | GreenLight
Genprex
Investor Presentation
November 2024
novel gene therapy diabetes program intends to address both and | Genprex
AbCellera
Investor Presentation
February 2024
a potential first in class antibody therapy for metabolic and endocrine conditions | AbCellera
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights